The results showed that serum miR-122 levels in HNFA-DM patients were lower than those in T2DM patients and healthy controls, while no differences were observed among T2DM, GCK-DM, MDM, and T1DM patients and healthy controls. This evidence concerns the gene GCK and diabetes mellitus.